NIH PAR · NICHD · X01
PAR-27-111: Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this notice of funding opportunity (NOFO) is to provide investigators with a mechanism to request services from the state-of-the-art Biological Testing Facility that would advance their contraceptive development or reproductive health programs. This NOFO aims to position innovative and validated methods for future regulatory submission and/or clinical development. Applicants do not need to have current NIH funding to apply, but priority may be given to programs receiving NIH support at the time of application submission.
- NOFO number
- PAR-27-111
- Type
- PAR
- Activity code
- X01
- Primary institute
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Clinical trials
- Not Allowed
- Posted
- Jun 1, 2026
- Opens
- Aug 7, 2026
- Expires
- May 8, 2029
PAR-27-111 due dates
8 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) |
|---|
| September 7, 2026 |
| January 4, 2027 |
| May 3, 2027 |
| September 6, 2027 |
| January 3, 2028 |
| May 1, 2028 |
| September 4, 2028 |
| January 2, 2029 |
| May 7, 2029 |
Funded projects
NIH RePORTER lists no awards under PAR-27-111 in FY2022–FY2026. Awards usually appear a few months after the first review cycle.
Participating institutes
2 NIH institutes and offices take applications under PAR-27-111. Contact the program officer at the institute that fits your research before applying.
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- none
Related notices
NIH lists no related notices for PAR-27-111 yet.
Award terms
- Application types allowed
- New The OER Glossary and the How to Apply - Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Not applicable. There is no budget associated with X01 Resource Access Awards.
- Project period
- The scope of the proposed project should determine the project period. The maximum project period is one year. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- Not applicable; there are no funds associated with a resource access award. The number of projects granted access to the resource is contingent upon the number of meritorious applications and the capacity of the Biological Testing Facility.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-23-192.
Other open NOFOs for X01
- PAR-27-071Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)RMOD · next due Jan 11, 2027
- PAR-27-069Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)PM · next due Oct 30, 2026
- PAR-25-437Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)ECHO · next due Nov 4, 2026
- PAR-25-447NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)NHLBI · next due Feb 8, 2027
- PAR-27-051NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)NIDA · next due Apr 15, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.